Prokidney Corp (PROK)

$2.48 -0.50 (-16.78%)
Market Cap 729.82M
Revenue (ttm) 80,000.00
Net Income (ttm) -61.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -76,487.50%
Debt to Equity Ratio 0.00
Volume 8,276,500
Avg Vol 16,830,000
Day's Range N/A - N/A
Shares Out 294.28M
Stochastic %K 39%
Beta 1.74
Analysts Sell
Price Target $5.67

Company Profile

ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2...

Industry: Biotechnology
Sector: Healthcare
Phone: 336 999 7028
Address:
2000 Frontis Plaza Blvd., Suite 250, Winston-Salem, United States
Space2
Space2 Sep. 15 at 4:19 AM
$PROK A possible scenario for today is 2.2$
0 · Reply
Asrm088
Asrm088 Sep. 13 at 5:34 PM
$PROK are we seeing higher ups here or nah?
0 · Reply
MomentumSpotter_
MomentumSpotter_ Sep. 12 at 8:35 PM
$GIPR $PROK $ABTC $CODA .....
0 · Reply
wavridr
wavridr Sep. 12 at 7:45 PM
$PROK ready for the 1 million share dump finale 💣
0 · Reply
JackSch
JackSch Sep. 12 at 6:58 PM
$PROK dumbass chicken shit bio stocks. It lost every penny it made yesterday 😀
0 · Reply
Theflash88
Theflash88 Sep. 12 at 6:55 PM
$PROK What did I miss?
0 · Reply
wavridr
wavridr Sep. 12 at 6:27 PM
$PROK 500k share blocks on the ask 😂
0 · Reply
wavridr
wavridr Sep. 12 at 6:26 PM
$PROK it should not be this easy! 🤣🤣🤣
0 · Reply
wavridr
wavridr Sep. 12 at 6:11 PM
$PROK next dump to 2.50 then 2.40 and 2.30 close. Printing unlimited shares in real time 😂
0 · Reply
michaelburryburner
michaelburryburner Sep. 12 at 4:55 PM
$PROK if I could load more back at $2-2.50 I would be very happy
1 · Reply
Latest News on PROK
ProKidney Corp. (PROK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 10:14 AM EDT - 6 days ago

ProKidney Corp. (PROK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 3, 2025, 2:08 PM EDT - 11 days ago

ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

Aug 27, 2025, 7:30 AM EDT - 18 days ago

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

Aug 12, 2025, 4:01 PM EDT - 4 weeks ago

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Jul 15, 2025, 7:30 AM EDT - 2 months ago

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

Jul 9, 2025, 11:22 AM EDT - 2 months ago

Trump's latest tariff threats and the impact on markets, ProKidney stock jumps over 500%

ProKidney: What's Happening With PROK Stock?

Jul 9, 2025, 8:45 AM EDT - 2 months ago

ProKidney: What's Happening With PROK Stock?

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 9, 2025, 7:30 AM EDT - 2 months ago

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Jul 8, 2025, 5:09 PM EDT - 2 months ago

ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying

Gold Falls 1%; ProKidney Shares Spike Higher

Jul 8, 2025, 1:25 PM EDT - 2 months ago

Gold Falls 1%; ProKidney Shares Spike Higher

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

Jul 8, 2025, 9:05 AM EDT - 2 months ago

Why Is Penny Stock ProKidney Trading Higher On Tuesday?

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

Jul 8, 2025, 7:00 AM EDT - 2 months ago

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

Jul 1, 2025, 12:43 PM EDT - 2 months ago

ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

May 12, 2025, 4:15 PM EDT - 4 months ago

ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Mar 17, 2025, 7:30 AM EDT - 6 months ago

ProKidney Reports Full Year 2024 Financial Results and Business Highlights

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

Jan 31, 2025, 11:08 AM EST - 8 months ago

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

Jan 31, 2025, 6:10 AM EST - 8 months ago

2025 Will Be A Major Year For ProKidney's Rilparencel In CKD Treatment

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

Nov 26, 2024, 7:30 AM EST - 10 months ago

ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

Nov 12, 2024, 7:30 AM EST - 10 months ago

ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

Nov 5, 2024, 7:30 AM EST - 11 months ago

ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

Oct 14, 2024, 7:30 AM EDT - 11 months ago

ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2024

ProKidney to Participate in the UBS Virtual Organ Restoration Day

Oct 9, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the UBS Virtual Organ Restoration Day

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

Sep 3, 2024, 7:30 AM EDT - 1 year ago

ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel's Registrational Path to Potential Approval in the U.S.

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 27, 2024, 7:30 AM EDT - 1 year ago

ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

Aug 9, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and Second Quarter 2024 Financial Results

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 11, 2024, 9:35 PM EDT - 1 year ago

ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

Jun 10, 2024, 4:15 PM EDT - 1 year ago

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

Jun 10, 2024, 6:30 AM EDT - 1 year ago

ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates

ProKidney to Participate in the Jefferies Global Healthcare Conference

May 29, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Participate in the Jefferies Global Healthcare Conference

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

May 21, 2024, 7:00 AM EDT - 1 year ago

ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

May 10, 2024, 7:00 AM EDT - 1 year ago

ProKidney Reports Business Updates and First Quarter 2024 Financial Results

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Mar 25, 2024, 6:05 AM EDT - 1 year ago

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

Mar 21, 2024, 7:49 PM EDT - 1 year ago

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

ProKidney to Participate in Jefferies Biotech on the Bay Summit

Feb 29, 2024, 4:05 PM EST - 1 year ago

ProKidney to Participate in Jefferies Biotech on the Bay Summit

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

Nov 30, 2023, 6:05 AM EST - 1 year ago

ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

Nov 21, 2023, 6:05 AM EST - 1 year ago

ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

Nov 16, 2023, 4:40 PM EST - 1 year ago

ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript

ProKidney Reports Third Quarter Financial Results

Nov 14, 2023, 6:05 AM EST - 1 year ago

ProKidney Reports Third Quarter Financial Results

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

Nov 13, 2023, 5:02 PM EST - 1 year ago

ProKidney Announces Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy (REACT®) for Diabetic CKD and Provides Corporate Updates

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

Oct 30, 2023, 4:12 PM EDT - 2 years ago

ProKidney Announces Four Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2023

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

Sep 5, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Morgan Stanley Global Healthcare Conference

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

Aug 10, 2023, 4:10 PM EDT - 2 years ago

ProKidney Reports Second Quarter Financial Results and Recent Corporate Highlights

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

Jul 18, 2023, 6:05 AM EDT - 2 years ago

ProKidney Announces Closing of Purchase of Manufacturing Facility in Greensboro, NC

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

Jul 15, 2023, 2:02 AM EDT - 2 years ago

ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

Jun 13, 2023, 12:05 PM EDT - 2 years ago

ProKidney Announces Purchase of Manufacturing Facility in Greensboro, NC

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

Jun 1, 2023, 4:05 PM EDT - 2 years ago

ProKidney to Participate in Fireside Chat at the Jefferies Healthcare Conference

ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights

May 11, 2023, 4:01 PM EDT - 2 years ago

ProKidney Reports First Quarter Financial Results and Recent Corporate Highlights

ProKidney to Present at the BofA Securities Health Care Conference 2023

May 4, 2023, 6:05 AM EDT - 2 years ago

ProKidney to Present at the BofA Securities Health Care Conference 2023

ProKidney: Too Many Billionaires, Too Little Data

Apr 12, 2023, 11:51 AM EDT - 2 years ago

ProKidney: Too Many Billionaires, Too Little Data

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights

Mar 28, 2023, 4:12 PM EDT - 2 years ago

ProKidney Reports Fourth Quarter Financial Results and Recent Corporate Highlights

Space2
Space2 Sep. 15 at 4:19 AM
$PROK A possible scenario for today is 2.2$
0 · Reply
Asrm088
Asrm088 Sep. 13 at 5:34 PM
$PROK are we seeing higher ups here or nah?
0 · Reply
MomentumSpotter_
MomentumSpotter_ Sep. 12 at 8:35 PM
$GIPR $PROK $ABTC $CODA .....
0 · Reply
wavridr
wavridr Sep. 12 at 7:45 PM
$PROK ready for the 1 million share dump finale 💣
0 · Reply
JackSch
JackSch Sep. 12 at 6:58 PM
$PROK dumbass chicken shit bio stocks. It lost every penny it made yesterday 😀
0 · Reply
Theflash88
Theflash88 Sep. 12 at 6:55 PM
$PROK What did I miss?
0 · Reply
wavridr
wavridr Sep. 12 at 6:27 PM
$PROK 500k share blocks on the ask 😂
0 · Reply
wavridr
wavridr Sep. 12 at 6:26 PM
$PROK it should not be this easy! 🤣🤣🤣
0 · Reply
wavridr
wavridr Sep. 12 at 6:11 PM
$PROK next dump to 2.50 then 2.40 and 2.30 close. Printing unlimited shares in real time 😂
0 · Reply
michaelburryburner
michaelburryburner Sep. 12 at 4:55 PM
$PROK if I could load more back at $2-2.50 I would be very happy
1 · Reply
SmartWentCrazy
SmartWentCrazy Sep. 12 at 4:52 PM
$PROK kind of interesting. I believe that drop triggers SSR for Monday.
0 · Reply
_www_larval_com_
_www_larval_com_ Sep. 12 at 4:42 PM
$PROK has dropped -4% lower to -10% (~3Mv) a moment ago, 09/19 options, follow for more volatility.
0 · Reply
wavridr
wavridr Sep. 12 at 4:42 PM
$PROK here we go.. finish this with a bigger dump than the pump 🪓
0 · Reply
Biohacker
Biohacker Sep. 12 at 3:41 PM
$PROK we will never know why yesterday happened,the mystery of bio penny stocks .
1 · Reply
wavridr
wavridr Sep. 12 at 2:28 PM
$PROK got stopped out 😂 wtf
0 · Reply
TrdrEG
TrdrEG Sep. 12 at 2:01 PM
$PROK just embarrassing
0 · Reply
SmartWentCrazy
SmartWentCrazy Sep. 12 at 1:58 PM
$PROK yesterday’s VWAP ended at 2.77, so this retrace to the VWAP level is expected.
0 · Reply
wavridr
wavridr Sep. 12 at 1:54 PM
$PROK back to normal 😂 short the fuk outta this now
0 · Reply
michaelburryburner
michaelburryburner Sep. 12 at 1:54 PM
$PROK very obvious we have picked up some short attackers, throw a short squeeze on this too
0 · Reply
Asrm088
Asrm088 Sep. 12 at 1:33 PM
$PROK this thing didn’t pan out as planned
1 · Reply
michaelburryburner
michaelburryburner Sep. 12 at 1:24 PM
$PROK PORK 🤣
0 · Reply
Strizzball
Strizzball Sep. 12 at 1:24 PM
$PROK for those wondering why the run see Morgan Stanley conference interview with PROK CEO. Great stuff.
2 · Reply